FORM 8-A

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                For Registration of Certain Classes of Securities
                    Pursuant to Section 12(b) or 12(g) of the
                         Securities Exchange Act of 1934


                             BOSTON BIOMEDICA, INC.
             (Exact Name of Registrant as Specified in its Charter)

 
            Massachusetts                              04-2652826
- ---------------------------------------     ------------------------------------
(State of Incorporation or Organization)    (I.R.S. Employer Identification No.)



             375 West Street, West Bridgewater, Massachusetts 02379
- --------------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

If this Form relates to the  registration 
of  a  class  of  debt  securities and is
effective   upon   filing   pursuant   to 
General    Instruction   A(c)(1)   please
check the following box. __

  

If  this  Form relates  to  the registration
of a  class of debt  securities  and  is  to
become    effective    simultaneously   with 
the    effectiveness     of    a  concurrent
registration statement under the  Securities
Act of 1933 pursuant to  General Instruction
A(c)(2) please check the following box. __




Securities to be registered pursuant to Section 12 (b) of the Act:

Title of Each Class                              Name of Each Exchange on Which
to be so Registered                              Each Class is to be Registered
- -------------------                              ------------------------------
       None                                                  None


Securities to be registered pursuant to Section 12 (g) of the Act:


                          Common Stock, $.01 par value
- --------------------------------------------------------------------------------
                                (Title of class)








Item 1.  Description of Registrant's Securities to be Registered.

         The  description  of the Common  Stock  contained  in the  Registration
Statement  on Form S-1 of  Boston  Biomedica,  Inc.  (No.  333-10759)  under the
Securities Act of 1933, filed on August 23, 1996, is incorporated herein by this
reference.  In addition,  the  description of the Common Stock  contained in the
final prospectus to be filed by the Registrant pursuant to Rule 424(b) under the
Securities Act of 1933 is incorporated herein by this reference.

Item 2.  Exhibits.

      1.  Amended and  Restated  Articles  of  Organization  of the  Registrant,
          previously  filed on October 8, 1996 as Exhibit 3.1 to Amendment No. 1
          to the Registration Statement, is incorporated herein by reference.

      2.  Amended and Restated  By-Laws of the Registrant,  previously  filed on
          October  8,  1996  as  Exhibit  No.  3.2  to  Amendment  No.  1 to the
          Registration Statement, is incorporated herein by reference.

      3.  Specimen  Certificate  for Shares of Common Stock,  $.01 par value per
          share, of the  Registrant,  filed on October 8, 1996 as Exhibit 4.1 to
          Amendment No. 1 to the Registration  Statement, is incorporated herein
          by reference.

                                    SIGNATURE

         Pursuant to the  requirements of Section 12 of the Securities  Exchange
Act of 1934, the Registrant  has duly caused this  registration  statement to be
signed on its behalf by the undersigned, thereto duly authorized.



(Registrant)      Boston Biomedica, Inc.
                  ---------------------------------------------------------

(Date)            October 24, 1996
                  ---------------------------------------------------------

(By)              /s/ Richard T. Schumacher
                  ---------------------------------------------------------
                   Richard T. Schumacher, President and Chief Executive Officer



                                      -2-